✦ LIBER ✦

Expression of Fas (APO-1/CD95) and Fas ligand (FasL) in human neuroblastoma

✍ Scribed by Gross, N. ;Balmas, K. ;Brognara, C. Beretta ;Tschopp, J.

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 222 KB
Volume: 36
Category: Article
ISSN: 0098-1532
DOI: 10.1002/1096-911x(20010101)36:1<111::aid-mpo1026>3.0.co;2-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Soluble Fas (APO-1, CD95) and soluble Fa

Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases

✍ Kazuhisa Nozawa; Nobuhiko Kayagaki; Yoshiaki Tokano; Hideo Yagita; Ko Okumura; H 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB

Apoptosis, proliferation, and Fas (APO-1

Apoptosis, proliferation, and Fas (APO-1, CD95)/Fas ligand expression in medullary carcinoma of the breast

✍ Evgeny Yakirevich; Lisa Maroun; Oded Cohen; Ofer Ben Izhak; Gad Rennert; Murray 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB 👁 1 views

Expression of FAS (CD95/APO-1) and FAS l

Expression of FAS (CD95/APO-1) and FAS ligand in lung cancer, its prognostic and predictive relevance

✍ Reet Koomägi; Manfred Volm 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 124 KB 👁 1 views

FIGURE 1 -Immunoblot analyses identify 40 kDa (Fas) and 45 kDa (FasL) proteins.

Differential regulation of CD95 (Fas/APO

Differential regulation of CD95 (Fas/APO-1) expression in human blood eosinophils

✍ Werner Luttmann; Alexander Opfer; Eva Dauer; Martin Foerster; Heinrich Matthys; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

Identification of the ligand binding sit

Identification of the ligand binding site in Fas (CD95) and analysis of Fas-ligand interactions

✍ Jürgen Bajorath 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB 👁 1 views

Fas (CD95), a member of the tumor necrosis factor receptor superfamily, and its ligand (FasL), a tumor necrosis factor-like protein, are intensely studied because their interaction on the cell surface is critical for the induction of programmed cell death (apoptosis) and the regulation of immune res

Regulation of CD95 (APO-1/ FAS) ligand a

Regulation of CD95 (APO-1/ FAS) ligand and receptor expression in squamous-cell carcinoma by interferon-γ and cisplatin

✍ Cordula Moers; Ulrich Warskulat; Markus Müschen; Jos Even; Dieter Niederacher; R 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 337 KB 👁 2 views

CD95 (Apo-1/Fas) ligand (CD95L) expression has been observed in various malignancies. In human primary cell lines from a squamous cell carcinoma (SCC) of the vulva, the effect of cisplatin (CDDP) and IFN␥ on the expression of CD95L and its 2 receptor isoforms, CD95 transmembrane (CD95tm) and CD95 so